Feasibility, complications, morbidity, and mortality results at 6 months for aneurysm treatment with the Flow Re-Direction Endoluminal Device: report of SAFE study
Last update on July 23, 2018
Selected in
Journal of NeuroInterventional Surgery by
Fausto FERRAZ